Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
about
The antioxidant master glutathione and periodontal healthFunctional Local Renin-Angiotensin System in Human and Rat Periodontal TissueOlmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis modelAzilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells.Atorvastatin decreases bone loss, inflammation and oxidative stress in experimental periodontitisAzilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease.Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line.Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars.Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters.Angiotensin II Type 1 Receptor Knockdown Impairs Interleukin-1β-Induced Cytokines in Human Periodontal Fibroblasts.
P2860
Q26775729-0B5F825A-19EE-4871-91D9-CA9A22F9DB7BQ27301201-1449B5D1-6A28-44C5-AA35-30E1B4DD387EQ28542802-0639674C-1BC8-414D-ABDB-53462E22BB9DQ31161038-64E4E0F4-3EEC-4B3D-8E06-C0CEEE58E494Q34433686-143C464C-FA5F-4324-8159-4E985578A6C0Q35018252-1CFCA320-CCC1-4F44-84E0-F3E313D2429BQ35562699-434FEC48-A7E5-4E37-AC80-8FC7474823CDQ38648056-07DD63BF-1178-4367-9090-A1D45EEB9982Q38857169-A1702939-0C16-4AB0-92ED-A72B4AD1F9F4Q40754287-2B38311B-070B-411D-9827-D8D724429F04Q41441856-24288593-6538-4CFB-86E7-353FA39218CDQ47616328-10CFB558-139D-4E1D-982A-35AF40EE487EQ51562398-26534502-7E8C-4492-91EF-0ACF35907EEF
P2860
Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@en
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@nl
type
label
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@en
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@nl
prefLabel
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@en
Olmesartan decreases IL-1β and ...... in experimental periodontitis.
@nl
P2093
P2860
P1476
Olmesartan decreases IL-1β and ...... in experimental periodontitis
@en
P2093
Caroline Addison Xavier de Medeiros
Gerly Anne de Castro Brito
Graziene Lopes de Souza
Karoline Sabóia Aragão
Maria do Socorro Costa Feitosa Alves
Raimundo Fernandes de Araújo
Tatiana Oliveira Souza
Yriu Lourenço
P2860
P2888
P304
P356
10.1007/S00210-013-0886-8
P577
2013-06-19T00:00:00Z